157 related articles for article (PubMed ID: 29404858)
21. Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model.
Gérard C; Bleyzac N; Girard P; Freyer G; Bertrand Y; Tod M
Pharm Res; 2011 Mar; 28(3):531-9. PubMed ID: 20963627
[TBL] [Abstract][Full Text] [Related]
22. Limited sampling strategies for estimating intravenous and oral cyclosporine area under the curve in pediatric hematopoietic stem cell transplantation.
Sarem S; Nekka F; Barrière O; Bittencourt H; Duval M; Teira P; Haddad E; Théorêt Y; Lapeyraque AL; Litalien C
Ther Drug Monit; 2015 Apr; 37(2):198-205. PubMed ID: 25162214
[TBL] [Abstract][Full Text] [Related]
23. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL
Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients.
Woillard JB; Lebreton V; Neely M; Turlure P; Girault S; Debord J; Marquet P; Saint-Marcoux F
Br J Clin Pharmacol; 2014 Oct; 78(4):836-46. PubMed ID: 24698009
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
Srinivas NR
Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
[TBL] [Abstract][Full Text] [Related]
27. A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.
Atiq F; Broers AE; Andrews LM; Doorduijn JK; Koch BC; Van Gelder T; Versmissen J
Eur J Clin Pharmacol; 2016 Jun; 72(6):719-23. PubMed ID: 26965514
[TBL] [Abstract][Full Text] [Related]
28. CsA exposure is associated with acute GVHD and relapse in children after SCT.
Willemze AJ; Press RR; Lankester AC; Egeler RM; den Hartigh J; Vossen JM
Bone Marrow Transplant; 2010 Jun; 45(6):1056-61. PubMed ID: 19881556
[TBL] [Abstract][Full Text] [Related]
29. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Junghanss C; Rathsack S; Wacke R; Weirich V; Vogel H; Drewelow B; Mueller S; Altmann S; Freund M; Lange S
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1061-8. PubMed ID: 22182476
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of pretransplantation cyclosporine pharmacokinetic studies on initial post-transplantation dosing in pediatric kidney allograft recipients.
Seikku P; Hoppu K; Jalanko H; Holmberg C
Pediatr Transplant; 2003 Apr; 7(2):102-10. PubMed ID: 12654050
[TBL] [Abstract][Full Text] [Related]
31. Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Behfar M; Koochakzadeh L; Yazdanian N; Salajegheh P; Rostami T; Khodayari-Namini N; Ghavamzadeh A; Hamidieh AA
Turk J Pediatr; 2019; 61(3):407-412. PubMed ID: 31916719
[TBL] [Abstract][Full Text] [Related]
32. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics.
Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T
Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532
[TBL] [Abstract][Full Text] [Related]
33. The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.
Skeens MA; Dietrich MS; Ryan-Wenger N; Gilmer MJ; Mulvaney SA; Akard TF
Pediatr Transplant; 2019 Aug; 23(5):e13451. PubMed ID: 31066981
[TBL] [Abstract][Full Text] [Related]
34. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.
Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
Bone Marrow Transplant; 2003 Oct; 32(8):777-84. PubMed ID: 14520421
[TBL] [Abstract][Full Text] [Related]
35. [Cytomegalovirus infection and immunosuppressant treatment in allogeneic hematopoietic stem cell transplantation recipients].
Xie W; Zhang X; Peng G; Yi B; Liu W; Zhong B; Jian Z; Fan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1162-6. PubMed ID: 21131738
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Barkholt L; Remberger M; Bodegård H; Ringdén O; Böttiger Y
Bone Marrow Transplant; 2007 Oct; 40(7):683-9. PubMed ID: 17660840
[TBL] [Abstract][Full Text] [Related]
37. Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
Bleyzac N; Cuzzubbo D; Rénard C; Garnier N; Dubois V; Domenech C; Goutagny MP; Plesa A; Grardel N; Goutelle S; Janoly-Duménil A; Bertrand Y
Bone Marrow Transplant; 2016 May; 51(5):698-704. PubMed ID: 26808568
[TBL] [Abstract][Full Text] [Related]
38. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
[TBL] [Abstract][Full Text] [Related]
39. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Yan CH; Xu LP; Liu DH; Chen H; Wang Y; Wang JZ; Wang FR; Han W; Liu KY; Huang XJ
Clin Transplant; 2015 Jul; 29(7):594-605. PubMed ID: 25969866
[TBL] [Abstract][Full Text] [Related]
40. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
